IL92015A0 - Tissue plasminogen activator muteins and processes for the preparation thereof - Google Patents

Tissue plasminogen activator muteins and processes for the preparation thereof

Info

Publication number
IL92015A0
IL92015A0 IL92015A IL9201589A IL92015A0 IL 92015 A0 IL92015 A0 IL 92015A0 IL 92015 A IL92015 A IL 92015A IL 9201589 A IL9201589 A IL 9201589A IL 92015 A0 IL92015 A0 IL 92015A0
Authority
IL
Israel
Prior art keywords
muteins
processes
preparation
plasminogen activator
tissue plasminogen
Prior art date
Application number
IL92015A
Other languages
English (en)
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of IL92015A0 publication Critical patent/IL92015A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL92015A 1988-10-24 1989-10-17 Tissue plasminogen activator muteins and processes for the preparation thereof IL92015A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3836200A DE3836200A1 (de) 1988-10-24 1988-10-24 Domaenenduplikations-muteine des gewebsplasminogen-aktivators (t-pa)

Publications (1)

Publication Number Publication Date
IL92015A0 true IL92015A0 (en) 1990-07-12

Family

ID=6365810

Family Applications (1)

Application Number Title Priority Date Filing Date
IL92015A IL92015A0 (en) 1988-10-24 1989-10-17 Tissue plasminogen activator muteins and processes for the preparation thereof

Country Status (6)

Country Link
EP (1) EP0366091A3 (da)
JP (1) JPH02215384A (da)
AU (1) AU609337B2 (da)
DE (1) DE3836200A1 (da)
DK (1) DK528989A (da)
IL (1) IL92015A0 (da)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63501841A (ja) * 1985-12-20 1988-07-28 ジ・アップジョン・カンパニ− 組織プラスミノ−ゲンアクチベ−タ−（ｔｐａ）同族体
AU600463B2 (en) * 1985-12-20 1990-08-16 Pharmacia & Upjohn Company Tissue plasminogen activator (tpa) analogs
DE3682891D1 (de) * 1986-02-17 1992-01-23 Stichting Centraal Lab Gewebeplasminogen-aktivator-mutant, dafuer kodierende rekombinante genetische information und verfahren zur herstellung dieser mutanten, deren verwendung und pharmazeutische zusammensetzungen.
GB8608020D0 (en) * 1986-04-02 1986-05-08 Beecham Group Plc Compounds
ATE110772T1 (de) * 1987-06-04 1994-09-15 Zymogenetics Inc Mutierter t-pa mit kringle-ersatz.

Also Published As

Publication number Publication date
AU4365789A (en) 1990-04-26
DE3836200A1 (de) 1990-04-26
AU609337B2 (en) 1991-04-26
EP0366091A3 (de) 1990-09-05
JPH02215384A (ja) 1990-08-28
DK528989D0 (da) 1989-10-24
EP0366091A2 (de) 1990-05-02
DK528989A (da) 1990-04-25

Similar Documents

Publication Publication Date Title
GB2221390B (en) Niacin-containing composition and its therapeutic use
IL89194A0 (en) Carcass chiller and sterilizer
AU1713188A (en) Manipulating and anchoring tissue
AU3877493A (en) Manipulating and anchoring tissue
EP0351314A3 (en) Medical material and medical implement
EP0330496A3 (en) Skin treatment composition
IL90690A0 (en) Tissue equivalents and their preparation
AU6806487A (en) Tissue plasminogen activator
AP9000161A0 (en) Insecticidal treatment and composition therefor
GB8820185D0 (en) New medical use
ZA893782B (en) Composition and use
NZ227594A (en) Human interleukin-1alpha and preparations thereof
IL89429A0 (en) Imidazolylmethyloxiranes and their use as fungicides
GB2215214B (en) Surgical dressing
GB8912373D0 (en) Medicament for various skin and ulcer disorders
IL92015A0 (en) Tissue plasminogen activator muteins and processes for the preparation thereof
GR900300003T1 (en) 3-aminodihydrothiophene-2-one peptide derivatives, processes for the preparation and therapeutic use
ZA893261B (en) Synergistic combinations and their use as therapeutic agents
GB8901422D0 (en) New tissue plasminogen activator
GB8815245D0 (en) New tissue plasminogen activator
GB8807186D0 (en) Surgical vizors
AU7090787A (en) Tissue plasminogen activator
GB8826692D0 (en) Tissue plasminogen activator
GB8815247D0 (en) New tissue plasminogen activator
GB8815246D0 (en) New tissue plasminogen activator